Thousands Sue Weight Loss Drug Manufacturers With Serious Harm AllegationsBy Anthony Yates Thousands of people have come forward alleging serious harm caused by GLP-1 weight loss drugs. Those products include Ozempic, Wegovy, and Mounjaro. According to a report by USA Today, at least 4,400 people have filed lawsuits since the first was filed in 2023. Those suits are now part of a consolidated federal and state litigation and target two drugmakers: Novo Nordisk, which manufactures Ozempic, and Eli Lilly, which makes Trulicity, Mounjaro, and Zepbound. The companies reportedly said they refute the allegations and will defend the safety of their products. The USA Today report focuses on three troubling cases in the growing lawsuit. 63-year-old Todd Engel was using Ozempic to manage his diabetes. However, he told the outlet that he lost vision in one eye after using the drug for four months. His medication reportedly never came up as a potential cause of his sight loss, and he lost vision in his other eye months later. 72-year-old JoHelen McClain reportedly used Wegovy in November 2023, aiming to shed a few pounds. In March 2024, she heard a noise like a "balloon popping," which she later discovered was the sound of her colon rupturing. USA Today also interviewed Mark Smith. He told the outlet that his wife, 62-year-old Robin Smith, was taking Mounjaro for weight loss. She reportedly visited the hospital twice for vomiting. Her doctor suggested she stop using the drug, but her problems persisted. Days later, doctors diagnosed her with Wernicke's encephalopathy, which the outlet explains is a neurological condition caused by a lack of thiamine or Vitamin B1. It's often linked to malnutrition. The outlet points out that an estimated 12% of Americans use GLP-1 weight-loss drugs and that the plaintiff's account for a small percentage of users. USA Today also cites a 2024 court filing by the two drug companies. They explain that the known risks are reflected in FDA-approved labeling, which the FDA has reviewed more than 40 times. USA Today details a Gallup Study, which claims that the usage of GLP-1 drugs doubled between 2024 and 2025.Chief of Research and Development at the St. Louis Veterans Affairs Health Care System, Ziyad Al-Aly, reportedly stated that no medicine is risk-free. However, he believes the benefits outweigh the risks for most patients. Legal challenges are expected to take several years. ARTICLE SOURCE: https://screenrant.com/thousands-sue-weight-loss-drug-manufacturers/
Recently I spotted Spam on sale for a good price so I picked one up. The ingredients aren't ideal, but it's a cost-effective option and, at least in my humble opinion, it's always good to have some canned meat in the pantry.
It also allows for a very simple and fast meal. You can always add to this simple base, but Spam (at least if you like the taste of Spam which I do) does a great job of carrying the dish on its own. You can substitute your preferred luncheon meat or corned beef if you desire.
Ingredients:
1 340g can Spam
6 eggs
1-2 tbsp fat for frying
Method:
1. Heat a frying pan over medium heat. Add 1-2 tbsp of ghee or your favorite fat or oil.
2. As the pan heats up uncan the Spam and cut into slices. Put Spam slices in pan to fry. Adjust heat if needed, I usually lower my burner to low (3) here.
3. Crack eggs into a bowl, add any additional seasoning you'd like to the eggs and beat.
4. Fry the Spam to your desired doneness and then use a spatula, spoon or a burger meat chopper to break up the Spam into smaller pieces.
5. Add scrambled eggs. Adjust head if needed, I usually lower mine to 2 here so I can leave it unattended for 5 minutes.
6. Flip and leave whole for a frittata style meal or break up into a scramble.
In this picture I only added a little bit of fresh ground black pepper to the eggs.
With my newly rediscovered love for the taste of Spam I'll probably eat this in some form once per week.